SRC and cancer: CSK inactivates the sarcoma (Src) family kinases which otherwise would lead to T-Cell antigen specific response by phosphorylating zeta chain T-cell receptor (TCR), which has been found downregulated for different cancer types, autoimmune disease and chronic inflammation48.